Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 2/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.37 |
| ▸ | PTGDR2 | Q9Y5Y4 | 11/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1934352 | 0.74 | MAPK1 (0.53) | PTGDR2CYP1A2TSHR | |
| SCHEMBL1934355 | 0.74 | MAPK1 (0.53) | PTGDR2CYP1A2TSHR | |
| SCHEMBL12343777 | 0.73 | PTGDR2 (0.38) | PTGDR2 | |
| SCHEMBL11939511 | 0.71 | HIF1A (0.56) | CYP1A2TSHR | |
| SCHEMBL4124579 | 0.67 | MAPK1 (0.45) | PTGDR2CYP1A2TSHR | |
| SCHEMBL4114087 | 0.67 | MAPT (0.49) | PTGDR2CYP1A2TSHR | |
| SCHEMBL16694297 | 0.67 | COXFA4 (0.52) | PTGDR2CYP1A2TSHR | |
| SCHEMBL16867638 | 0.67 | COXFA4 (0.52) | PTGDR2CYP1A2TSHR | |
| SCHEMBL2047943 | 0.65 | CYP1A1 (0.47) | CYP1A1CYP1B1CYP1A2TSHR | |
| SCHEMBL1581546 | 0.63 | PTPN1 (0.48) | CYP1A1CYP1B1CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022208169-A1 | PULSATILE PROTOCOLS FOR CANCER TREATMENT METHODS AND USES | CLINICS OPERATIONS LIMITED (GB) | 2022-10-06 | — | — | WO | disclosed |